Laboratory indicators and liver transplantation characteristics
Analysis of preoperative laboratory indicators (Table 2), including
blood tests (WBC, HBG, NE, PLT), liver and kidney functions (ALT, AST,
TBIL, DBIL, ALB, AKP, γ-GGT, BUN, CREA), blood glucose (GLU),
coagulation function (PT, INR), and blood lipids (TG, CHOL) between the
PTLD group and the control group revealed that there were statistically
significant differences in postoperative platelets, ALT, AST, CHOL and
serum tacrolimus concentration (P<0.05). The patient was
administered tacrolimus (anti-rejection treatment plan) after liver
transplantation; therefore, their serum tacrolimus concentrations were
continuously monitored. Statistical analysis revealed that the average
serum tacrolimus concentrations of patients in the PTLD and control
groups were 8.28±1.61 ng/mL and 7.32±1.63ng/mL, respectively,
postoperative. Similarly, a statistically significant difference was
observed between the serum tacrolimus concentrations of the PTLD and
control groups (P<0.05) (Table 2).
As shown in Table 2, graft weight, graft body weight ratio, transplant
type, intraoperative blood loss, and blood type were not related to the
occurrence of PTLD.